Search results :

Meloxicam

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: M01AC06

Side effects

Options: Show MedDRA Preferred Terms,   display all 51 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Gastrointestinal disorder postmarketing, 9% - 18.9% 9.6% - 14.1% x x x x x x x x x x x
Dyspepsia 2.7% - 9.5% 3.2% - 4.5% x x x x x x x x x x x x x x x x x x x
Infestation NOS 0.5% - 7% 0.2% - 4.1% x x x x x x x x x x x
Dyspeptic signs and symptoms 4% - 5.8% 3.8% x x x x x x x x
Headache 0% - 9.3% 3.4% - 10.2% x x x x x x x x x x x x x x x x x x x
Influenza-like symptoms 2.3% - 5.8% 2.1% - 5.1% x x x x x x x x x x x x
Nausea 0.47% - 7.7% 0% - 3.2% x x x x x x x x x x x x x x x x x x x
Nervous system disorder 0.6% - 9.3% 0% - 6.4% x x x x x x x x x x x x x x
Infection 0% - 8.3% 0.2% - 4.1% x x x x x x x x x x x x x
Upper respiratory tract infection 0% - 8.3% 1.9% - 4.1% x x x x x x x x x x x x x x x
Diarrhoea 0.6% - 9.2% 2.5% - 5.3% x x x x x x x x x x x x x x x x x x
Accident at home 2.6% - 4.5% 1.9% x
Flatulence 0.4% - 5.5% 1.1% - 4.5% x x x x x x x x x x x x x x x x x
Pain 0.9% - 5.2% x x x x x x x x x
Influenza 2.3% - 2.9% 2.1% x
Abdominal pain 1.1% - 28.1% 0.6% - 17.2% x x x x x x x x x x x x x x x x x x x
Influenza like illness 2.1% - 5.8% 2.1% - 5.1% x x x x x x x x x x
Dizziness 0% - 3.8% 1.9% - 3.2% x x x x x x x x x x x x x x x x x x
Oedema 0.6% - 4.5% 2.5% x x x x x x x x x x x x x x x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing, 0% - 4.5% 0% - 1.7% x x x x x x x x x x x x x x
Joint related signs and symptoms 1.5% - 2.3% 1.9% x x x x x x x x x x
Nasopharyngitis 0% - 1.9% 0.6% x x
Sinusitis 1.3% - 5.9% 1.3% - 5.1% x x x x x
Rheumatoid arthritis 1.5% - 2.3% 2.3% x
Anaemia 0% - 4.1% x x x x x x x x x x x x x x x x
Connective tissue disorder 0.6% - 2.6% 1.3% - 1.9% x x x x x x x x x x x
Arthralgia 0% - 5.3% 0% - 1.9% x x x x x x x x x x x x x x x x
Bursitis 0% - 1.9% 0.6% x x
Carpal tunnel syndrome 0.6% - 1.3% 0% x x
Constipation 0% - 3.9% 0.6% - 1.9% x x x x x x x x x x x x x x x x
Rash 0% - 3.8% 0.6% - 2.5% x x x x x x x x x x x x x x x x x x x
Gastrooesophageal reflux disease 0% - 1.9% 0% x x x x x x x x x x x x x x x x
Mediastinal disorder 0.6% - 2.2% 0.6% - 1.5% x x x x
Pharyngitis 0.6% - 3.2% 0.6% - 1.3% x x x x x x x x x x x x x x x x
Muscle spasms 1.3% - 1.9% 1.3% x x x x
Urinary tract infection 0.3% - 6.9% 1.3% x x x x x x x x x x x x
Cataract 0% - 1.3% 0% x x
Hypersensitivity 0% - 1.9% 0.4% - 1.9% x x x x x x x x x x x x x x x
Cough 0.2% - 2.4% 0.6% - 1.5% x x x x x x x x x x x x x
Rhinitis 0.6% - 1.1% 0.4% x x
Malnutrition 0% - 1.3% 0% - 1.3% x x x
Myalgia 0% - 1.3% 0% - 0.2% x x
Abdominal pain upper 0% - 1.9% 0.9% x x
Immune system disorder postmarketing, 0% - 1.9% 0.4% - 1.9% x x x x
Pollakiuria 0.1% - 2.4% x x x x x x x x x x
Vomiting 0% - 2.6% 1.1% - 2.3% x x x x x x x x x x x x x x x x
Back pain 0.4% - 3% 2.3% - 3.2% x x x x x x x x x x x x x x
Dyspnoea 0% - 1.3% 0% x x x x x x x x x x x x x x x
Ear disorder 0% - 1.3% 0% x x
Haematuria 0% - 1.3% 0.6% x x x x x x x x x x x x x x x x
Pain in extremity 0.6% - 1.3% 0% x x
Purpura 0% - 1.9% 0.2% - 1.3% x x x x x x x x x x x x x x x x
Urinary tract disorder postmarketing, 0% - 1.3% 0.6% x x x x
Vertigo 0.4% - 3% 0% - 3% x x x x x x x x x x x x x x x x x x
Mental disorder postmarketing, 0% - 2% 0% - 0.6% x x x x x x x x
Bronchitis 0.5% - 1.3% 0.2% x x
Fatigue 0% - 2.2% 0% - 1.9% x x x x x x x x x x x x x x x x
Hypertension 0% - 2.2% 0.6% - 2.5% x x x x x x x x x x x x x x x x x x
Pruritus 0% - 2.4% 0.6% - 1.3% x x x x x x x x x x x x x x x x x x
Angiopathy 0% - 2.2% 0.6% - 2.5% x x x x x
Oedema peripheral 0% - 3.2% 0% - 1.3% x x x x x x x x x
Gravitational oedema 0% - 3.3% 0% - 0.6% x x x x x x x x x
Ear and labyrinth disorders 0% - 1.3% 0% - 0.6% x x x x x
Insomnia 0% - 3.6% 0% - 0.6% x x x x x x x x x x x x x
Eye disorder postmarketing, 0% - 1.3% 0% - 1.1% x x x x x
Gastrointestinal haemorrhage 0% - 1.1% 0% x x x x x x x x x x x x x x x x x x
Blood urea increased 0% - 1.1% 0% x x x x x x x x x x x x
Increased appetite 0% - 1.3% 0.6% x x x x x x x x x x x x x x x x
Gastritis postmarketing, 0% - 1.6% 0% x x x x x x x x x x x x x x x x x
Dry mouth 0% - 1.3% 0% x x x x x x x x x x x x x x
Melaena 0% - 1.1% 0% x x x x x x x x x x x x x x
Tinnitus 0% - 1.3% 0% - 0.6% x x x x x x x x x x x x x x x x x
Hepatic function abnormal 0% - 1.1% 0% x
Creatinine renal clearance decreased 0% - 1.1% 0% x
Rash erythematous 0% - 1.1% 0% x x x x x x x
Hepatobiliary disease postmarketing, 0% - 1.1% 0% x x x x x
Somnolence 0% - 1.1% 0% x x x x x x x x x x x x x x x x x
Agranulocytosis postmarketing x x x x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x
Angina pectoris postmarketing x x x x x x x x x x x x x x x
Angioedema postmarketing x x x x x x x x x x x x x x x x x x
Arrhythmia postmarketing x x x x x x x x x x x x x x x
Confusional state postmarketing x x x x x x x x x x x x x x x x x x
Conjunctivitis postmarketing x x x x x x x x x x x x x x x x x x
Dermatitis exfoliative postmarketing x x x x x x x x x x
Toxic epidermal necrolysis postmarketing x x x x x x x x x x x x x x x x x x
Erythema multiforme postmarketing x x x x x x x x x x x x x x x x
Cardiac failure postmarketing x x x x x x x x x x x x x x x x
Hepatitis postmarketing x x x x x x x x x x x x x x x x x x
Type I hypersensitivity postmarketing x x x x x
Jaundice postmarketing x x x x x x x x x x x x x x
Renal failure acute postmarketing x x x x x x
Meningitis postmarketing x x
Myocardial infarction postmarketing x x x x x x x x x x x x x x x x
Nephritis interstitial postmarketing x x x x x x x x x x x x x
Convulsion postmarketing x x x x x x x x x x x x x x x
Shock postmarketing x x x x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x x x x
Vasculitis postmarketing x x x x x x x x x x x x x x x
Hepatic failure postmarketing x x x x x x x x x x x x x x x
Mood swings postmarketing x x x x
Dermatitis bullous postmarketing x x x x x
Disorientation postmarketing x x x x x x
Anaphylactoid reaction postmarketing x x x x x x x x x x x x x x x x x x
Acute retention of urine postmarketing x x x x x x x x x x x x x x
Vision blurred postmarketing x x x x x x
Albuminuria x x x x x x x x x x x x x x
Alopecia x x x x x x x x x x x x x
Anxiety x x x x x x x x x x x x x x
Arthritis 0% - 1.9% 0% x x
Asthma x x x x x x x x x x x x x x x
Bronchospasm x x x x x x x x x x x x x x
Pleuritic pain 0% - 1.3% 0% x x
Colitis x x x x x x x x x x x x x x x x
Cytopenia x x x x x
Dehydration 0% - 1.3% 0% x x x x x x x x x x x x x x x
Dermatitis x x
Drowsiness x
Duodenal ulcer x x x x x x x x x x x x x x
Dysgeusia x x x x x x x x x x x x x x
Eructation 0% - 1.3% 0% x x x x x x x x x x x x x x x x x x
Oesophagitis x x x x x x x x x x x x x x x x x
Body temperature increased x x x x x x x x x x x x x x
Flushing x x x x x
Cardiac disorder x x x x
Cardiac failure congestive x x x x x x x x
Haematemesis x x x x x x x x x x x x x x
Haemorrhage x x
Hyperbilirubinaemia x x x x x x x x x x x x x
Hyperhidrosis 0% - 1.3% 0% x x x
Hypotension x x x x x x x x x x x x x x
Intestinal perforation x x x x x x x x x x
Labyrinthine disorder x
Laryngitis x x x
Leukopenia x x x x x x x x x x x x x x x x x x
Low back pain x
Meningitis aseptic x
Musculoskeletal pain x x
Nephritis x x x
Nervousness x x x x x x x x x x x x x x
Palpitations x x x x x x x x x x x x x x x x x x
Pancreatitis x x x x x x x x x x x x x x
Paraesthesia x x x x x x x x x x x x x x
Peptic ulcer x x x x
Renal failure x x x x x x x x x x x x x
Respiratory tract infection x
Sciatica x
Ankylosing spondylitis x
Gastric ulcer x x x x x x x x x x x x x x
Stomatitis x x x x x x
Ulcerative stomatitis x x x x x x x x x x x x x
Sweating x x x
Swelling x
Syncope x x x x x x x x x x x x x x
Tachycardia x x x x x x x x x x x x x
Thrombocytopenia x x x x x x x x x x x x x x x x x
Tremor x x x x x x x x x x x x x x
Ulcer x x x x x x x x
Erythema x x
Urticaria x x x x x x x x x x x x x x x x x
Disorder sight x
Weight increased x x x x x x x x x x x x x
Weight decreased x x x x x x x x x x x x x x
Wheezing x
Urinary retention x
Mouth ulceration 0% - 2.3% 0% x
Creatinine increased x x x x x x x x x x x x x
Gamma-glutamyltransferase increased x x x x x x x x x x
Gastrointestinal perforation x x x x
Kidney function abnormal x x
Liver function test abnormal x x x
Aspartate aminotransferase increased x x x x x x x x x x x x x
Alanine aminotransferase increased x x x x x x x x x x x x
Joint swelling x x x
Photosensitivity reaction x x x x x x x x x x x x x x x x
Lightheadedness x x
Stomach ache x
Malaise x x x x x x x x x x x x x x
Joint crepitation x x x
Bullous eruption x x x x x x x x x x x x x x
Leg edema x x x x x x
Renal function test abnormal x x x
Gastric ulcer perforation x x x x x x x x x x x x x x
Asthmatic attack x x x
Photosensitivity x
Red blood cell abnormality 0% - 1.1% 0.6% x
Rash maculo-papular x x x x x x
Blood pressure increased x x
Face oedema x x x x x x x x x x x x x x
Visual disturbance postmarketing, 0% - 0.6% 1.1% x x x x x x
Arthralgia aggravated x x x
Serum potassium increased x
Hot flush x x x x x x x x x x x x x x
Drug interaction x
Serum creatinine increased x x x x x
Sweating increased x x x x x x x x x x x
Duodenal ulcer perforation x x x x x x x x x x x x x
Blood and lymphatic system disorders 0% - 1.1% 0.6% x x x x x
General disorders and administration site conditions
Dyspepsia aggravated x x x
Back pain aggravated x x
Joint effusion x x x
Vascular purpura x
Blood count abnormal x x x
Appetite absent x
Gastrointestinal tract irritation x x x
Abnormal vision x x x x x x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

MELOXICAM

Side effects:14
Source:FDA Structured Product Label

MELOXICAM

Side effects:20
Source:FDA Structured Product Label

Meloxicam tablets / Meloxicam 7.5, Tablet

Side effects:62
Source:Medsafe

MOBIC / Mobic, Tablet

Side effects:67
Source:Medsafe

MELOXICAM

Side effects:94
Source:FDA Structured Product Label

meloxicam

Side effects:104
Source:FDA Structured Product Label

MELOXICAM

Side effects:105
Source:FDA Structured Product Label

meloxicam

Side effects:108
Source:FDA Structured Product Label

MELOXICAM

Side effects:108
Source:FDA Structured Product Label

Meloxicam

Side effects:110
Source:FDA Structured Product Label

MELOXICAM

Side effects:111
Source:FDA Structured Product Label

MELOXICAM

Side effects:112
Source:FDA Structured Product Label

Meloxicam / Moxicam

Side effects:113
Source:medicines.org.au

MELOXICAM

Side effects:114
Source:FDA Structured Product Label

MELOXICAM

Side effects:114
Source:FDA Structured Product Label

MELOXICAM

Side effects:114
Source:FDA Structured Product Label

MELOXICAM / PHL-MELOXICAM

Side effects:118
Source:Health Canada

MELOXICAM

Side effects:125
Source:FDA Structured Product Label

MELOXICAM / MOBICOX

Side effects:135
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label